Biosergen AS
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Holding, Public
- Established
- 2004-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://biosergen.net
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Biosergen AS
- Target Recruit Count
- 15
- Registration Number
- NCT06678113
- Locations
- 🇮🇳
JSS Medical Research Asia Pacific Private Limited, Dehli, Haryana, India
A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.
Phase 1
Recruiting
- Conditions
- Invasive Fungal Infections
- Interventions
- Drug: BSG005 or placebo
- First Posted Date
- 2021-06-10
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Biosergen AS
- Target Recruit Count
- 72
- Registration Number
- NCT04921254
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
News
No news found